BIT
BIOC

BlackRock Institutional Trust’s Biocept, Inc. BIOC Stock Holding History

BlackRock Institutional Trust’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$44K Hold
6
– – ﹤0.01% 3720
2016
Q3 		$89K Hold
6
– – ﹤0.01% 3708
2016
Q2 		$113K Hold
6
– – ﹤0.01% 3689
2016
Q1 		$220K Hold
6
– – ﹤0.01% 3614
2015
Q4 		$235K Hold
6
– – ﹤0.01% 3630
2015
Q3 		$392K Buy
+6
New +$375K ﹤0.01% 3543
2015
Q2 		– Hold
0
– – – 3886

Other funds holding BIOC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

BlackRock Institutional Trust's BIOC Position: Q4 2016 in Review

BlackRock Institutional Trust held its Biocept, Inc. (BIOC) position steady in Q4 2016 at 6 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #3720.

BlackRock Institutional Trust first reported a position in BIOC in Q3 2015 and has held it in 6 quarters since. The position peaked at $392K in Q3 2015. 8 funds tracked by Wall St. Rank hold BIOC as of Q4 2016.

  • BlackRock Institutional Trust held 6 shares of Biocept, Inc. worth $44K as of Q4 2016.
  • BlackRock Institutional Trust left its Biocept, Inc. share count unchanged in Q4 2016.
  • Biocept, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3720 holding.
  • BlackRock Institutional Trust first reported a position in Biocept, Inc. in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Biocept, Inc. position peaked at $392K in Q3 2015.
  • 8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.